Study finds adverse effects in treatment for primary sclerosing cholangitis
Wednesday, August 19, 2009 - 11:07
in Health & Medicine
Primary sclerosing cholangitis (PSC) is an uncommon chronic liver disease characterized by progressive inflammation and destruction of the bile ducts. The disease progresses slowly, usually leading to biliary cirrhosis, portal hypertension and liver failure over a 10-15 year period.